Viewing Study NCT03630159


Ignite Creation Date: 2025-12-24 @ 2:24 PM
Ignite Modification Date: 2026-02-20 @ 4:45 PM
Study NCT ID: NCT03630159
Status: COMPLETED
Last Update Posted: 2022-08-15
First Post: 2018-08-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Tisagenlecleucel in Combination With Pembrolizumab in r/r Diffuse Large B-cell Lymphoma Patients
Sponsor:
Organization: